In many respects, the cannabis industry is now just coming on-line into full facility care cleaning. Facility care has been happening for decades now and occurs in areas like Pharma & Food product producing facilities, as well as Hospitals and Long Term Care facilities where pathogens and words like nosocomial are well understood. Much of what has been learned in the cleaning industry is tried and true and we’ve come to know what we now know, largely through failure, so our ambition is to disseminate some failure avoidance principals and focus on the business of cleaning, to support the business of cannabis on the following themes:
Broad Facility Care Discussion
IPA – Potential Health and Environmental Risk
Danger in the workplace – Multi-faceted discussion – Worker and Environment
WHMIS, as it relates to the worker and Cannabis production facilities
Green Cleaning and GreenGuard Gold certification for cleaning chemicals used indoors
Production – Equipment to task as opposed to labour to task
Training – Specific to facility care knowledge
Building Service Contractors – Their place in the cannabis industry
Cannabis farmgate refers to a retail store where cannabis products are sold directly to customers by a federally licensed producer (LP), usually at their production site. Despite considerable publicity and apparent interest by the industry and consumers, uptake is at a very early stage. Ontario is the only province with cannabis farmgate operations, although Saskatchewan’s retail framework allows it. The BC government will launch a farmgate program in 2022. New Brunswick announced in late August 2021 that it will implement a farmgate program as soon as possible.
The presentation will explain what cannabis farmgate is and could become, looking at the prospects for different licensees, including cultivators. Ideas being discussed include using farmgate stores to promote cannabis tourism and providing tasting and sampling as with wineries and craft breweries. The presentation will review provincial governments’ moves to establish farmgate programming and conclude by considering the outlook for farmgate in applicable provinces. The scope for cultivators’ participation will be discussed with fresh insights from BC’s current consultation exercise.
Takeaways:
Learn the model’s key components.
Farmgate in many forms: can it work in any setting?
Opportunity for co-operative farmgate models and selling other producer’s products.
The model’s potential as a new sales channel and strategic driver of new business.
What’s the outlook for farmgate store openings across Canada?
These are the brightest minds in cannabis growth, sharing experiences, best practices and goodwill amongst growers. And this camaraderie will come in handy as the push for industry standardization grows. They’ll talk about a year of challenges, adjusting to regulations, and offer insight into how Health Canada can adjust its role to promote better growing and cannabis quality. Many relationships were forged among growers at the last event, and it’s not far-fetched to see a future advocacy group forming over the lunch table.
The past year has been a “reckoning” for the Canadian cannabis sector. Many cannabis companies remain unable to turn a profit; but that’s almost a success story compared to those struggling to make payroll and in some cases, even survive. Against this backdrop there are also success stories. The truth is, some cannabis companies have adapted and are finding a way to succeed.
This panel will bring together a group of people who understand the many challenges faced by cannabis companies and have unique insights into what it takes to succeed in Canadian cannabis. We will discuss what went wrong but more importantly, we will focus on what smart cannabis companies should be doing now to turn things around for sustainable success.
A tour de force of psilocybe mushrooms from historical use, legal status, growth cycles, understanding chemical makeup, and how psilocybin affects the brain and body.
Bruce Linton may forever be known for jumpstarting the Canadian cannabis industry as CEO of Canopy Growth. Or that may simply be known as his first home run. His next opportunity, Gage Cannabis, led the charge into the slowly loosening U.S. market via Michigan, with 19 “Class C” cultivation licenses, 15 dispensaries, and three processing licenses. And now, Gage has become a bigger player with the company’s all-stock $545 million purchase by TerrAscend. Bruce has graced us with his presence before, each time with some new venture percolating. In this keynote address, expect some hints of things to come.
There are big growers and there are micro-cultivators. And as strange as it may seem, there are more hoops to jump through and licenses to pay for if you decide to grow the cannabis equivalent of a craft beer. With processor licenses, sales licenses, nursery licenses and harvest limits, experts say a start-up could cost anywhere from $250k to $2 million. And yet, as consumer connoisseurship grows, and the willingness to pay for quality follows, micro-cultivators may be ideally suited to experiment with and grow higher-quality strains. This panel will examine the potential profit of limited-edition cannabis growing versus the cost.
Truly a global phenomenon, cannabis is finding devotees in all its incarnations, from recreational to hemp to medicinal (Israel, for example, recently passed Germany as the largest importer of medicinal flowers). There is practically no place in the world where demand does not tempt investors. At the same time, there are many countries that still outlaw the drug. And COVID-19 has created its own foreign investment barriers, from restrictions on retail and travel to supply chain disruptions. Various market research studies have tried to make sense out of the emerging international market. This session will tell you what we know, what we don’t know, and what the profit potential is from Africa to Asia to Europe to South America.
In a pandemic-stricken global economy, there is every reason to expect the worst. But despite what many consider high and/or unfair taxes, regulatory handcuffs and crippled supply chains, the durability of the cannabis industry has surprised many. In a research report from Prospiant and Cannabis Business Times, 31% of participants reported increased revenues in 2020 and 73% planned to imminently add cultivation space (indoor, outdoor or greenhouse). Is it overly optimistic to expect these trends to continue, or does this suggest better things to come? We’ll assess our industry’s strengths and its ability to endure.
Recent Comments